Gary E. Borodic

2.2k total citations
36 papers, 1.4k citations indexed

About

Gary E. Borodic is a scholar working on Neurology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Gary E. Borodic has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 12 papers in Pathology and Forensic Medicine and 9 papers in Dermatology. Recurrent topics in Gary E. Borodic's work include Botulinum Toxin and Related Neurological Disorders (21 papers), Neurological disorders and treatments (11 papers) and Facial Nerve Paralysis Treatment and Research (10 papers). Gary E. Borodic is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (21 papers), Neurological disorders and treatments (11 papers) and Facial Nerve Paralysis Treatment and Research (10 papers). Gary E. Borodic collaborates with scholars based in United States, Netherlands and Japan. Gary E. Borodic's co-authors include Eric A. Johnson, Robert J. Ferrante, L. Bruce Pearce, Martin A. Acquadro, Karen L. Smith, David J. Cozzolino, Michael P. Joseph, Edward J. Schantz, David M. Hinkle and Michael J. McKenna and has published in prestigious journals such as Neurology, Diabetes and FEBS Letters.

In The Last Decade

Gary E. Borodic

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary E. Borodic United States 19 1.1k 331 279 241 158 36 1.4k
Alessandro Lozza Italy 17 645 0.6× 205 0.6× 124 0.4× 202 0.8× 43 0.3× 47 1.1k
Andrew Blitzer United States 14 470 0.4× 125 0.4× 328 1.2× 100 0.4× 42 0.3× 31 1.0k
Yeşim Parman Türkiye 23 637 0.6× 482 1.5× 107 0.4× 85 0.4× 16 0.1× 98 1.6k
Namita Goyal United States 16 421 0.4× 125 0.4× 205 0.7× 56 0.2× 65 0.4× 64 1.2k
Maik Ellies Germany 16 408 0.4× 63 0.2× 225 0.8× 131 0.5× 46 0.3× 31 749
Elizabeth A. Sekul United States 13 404 0.4× 214 0.6× 56 0.2× 71 0.3× 50 0.3× 18 1.1k
P. van Doorn Netherlands 11 948 0.9× 659 2.0× 111 0.4× 106 0.4× 15 0.1× 21 1.3k
Daniel P. Stein United States 7 405 0.4× 178 0.5× 38 0.1× 147 0.6× 87 0.6× 8 1.1k
Ruple S. Laughlin United States 17 664 0.6× 305 0.9× 173 0.6× 86 0.4× 12 0.1× 65 1.1k
Eduardo Fernández Italy 22 478 0.4× 359 1.1× 102 0.4× 441 1.8× 10 0.1× 92 1.4k

Countries citing papers authored by Gary E. Borodic

Since Specialization
Citations

This map shows the geographic impact of Gary E. Borodic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Borodic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Borodic more than expected).

Fields of papers citing papers by Gary E. Borodic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary E. Borodic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Borodic. The network helps show where Gary E. Borodic may publish in the future.

Co-authorship network of co-authors of Gary E. Borodic

This figure shows the co-authorship network connecting the top 25 collaborators of Gary E. Borodic. A scholar is included among the top collaborators of Gary E. Borodic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary E. Borodic. Gary E. Borodic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borodic, Gary E.. (2023). Botulinum toxin type A in multimodal management of age-related macular degeneration and related diseases. Toxicon. 236. 107170–107170. 1 indexed citations
2.
Ma, Lina, Frederick A. Jakobiec, Natalie Wolkow, Thaddeus P. Dryja, & Gary E. Borodic. (2018). Multiple Eyelid Cysts (Apocrine and Eccrine Hidrocystomas, Trichilemmal Cyst, and Hybrid Cyst) in a Patient With a Prolactinoma. Ophthalmic Plastic and Reconstructive Surgery. 34(3). e83–e85. 2 indexed citations
3.
Borodic, Gary E., et al.. (2013). Parry-Romberg Syndrome Vasculopathy and Its Treatment With Botulinum Toxin. Ophthalmic Plastic and Reconstructive Surgery. 30(1). e22–e25. 17 indexed citations
4.
Borodic, Gary E.. (2013). Use of Fillers as Adjunct Therapy for the Treatment of Lower Face Hemifacial Spasm. Ophthalmic Plastic and Reconstructive Surgery. 29(3). 225–226. 2 indexed citations
5.
Jakobiec, Frederick A., et al.. (2012). Desmoplastic Trichoepithelioma. Ophthalmic Plastic and Reconstructive Surgery. 28(5). e121–e123. 4 indexed citations
6.
Borodic, Gary E., et al.. (2011). Drug-Induced Graves Disease From CTLA-4 Receptor Suppression. Ophthalmic Plastic and Reconstructive Surgery. 27(4). e87–e88. 93 indexed citations
7.
Pellett, Sabine, et al.. (2007). A neuronal cell‐based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Letters. 581(25). 4803–4808. 69 indexed citations
8.
Borodic, Gary E., William H. Slattery, Michael E. Glasscock, et al.. (2005). Botulinum Toxin for Aberrant Facial Nerve Regeneration: Double-Blind, Placebo-Controlled Trial Using Subjective Endpoints. Plastic & Reconstructive Surgery. 116(1). 36–43. 68 indexed citations
9.
Borodic, Gary E. & Martin A. Acquadro. (2002). The use of botulinum toxin for the treatment of chronic facial pain. Journal of Pain. 3(1). 21–27. 81 indexed citations
10.
Borodic, Gary E., Martin A. Acquadro, & Eric A. Johnson. (2001). Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opinion on Investigational Drugs. 10(8). 1531–1544. 100 indexed citations
11.
Tarsy, Daniel, Neil Bhattacharyya, & Gary E. Borodic. (2000). Myasthenia gravis after botulinum toxin a for Meige syndrome. Movement Disorders. 15(4). 736–738. 18 indexed citations
12.
Borodic, Gary E., James W. Karesh, Michael J. Tolentino, et al.. (1999). Giant cell angiofibroma of the orbit and eyelid. Ophthalmology. 106(6). 1223–1229. 31 indexed citations
13.
Pearce, L. Bruce, et al.. (1995). The median paralysis unit: A more pharmacologically relevant unit of biologic activity for botulinum toxin. Toxicon. 33(2). 217–227. 40 indexed citations
14.
Borodic, Gary E., Robert J. Ferrante, L. Bruce Pearce, & Karen L. Smith. (1994). Histologic assessment of dose‐related diffusion and muscle fiber response after therapeutic botulinum a toxin injections. Movement Disorders. 9(1). 31–39. 235 indexed citations
15.
Borodic, Gary E. & L. Bruce Pearce. (1994). New Concepts in Botulinum Toxin Therapy. Drug Safety. 11(3). 145–152. 6 indexed citations
16.
Borodic, Gary E., L. Bruce Pearce, Karen L. Smith, Michael W. Phelan, & Robert J. Ferrante. (1993). Botulinum B Toxin as an Alternative to Botulinum A Toxin. Ophthalmic Plastic and Reconstructive Surgery. 9(3). 182–190. 21 indexed citations
17.
Borodic, Gary E., L. Bruce Pearce, Karen L. Smith, & Michael P. Joseph. (1992). Botulinum a toxin for spasmodic torticollis: Multiple vs single injection points per muscle. Head & Neck. 14(1). 33–37. 54 indexed citations
18.
Borodic, Gary E., et al.. (1991). Innervation Zone of Orbicularis Oculi Muscle and Implications for Botulinum A Toxin Therapy. Ophthalmic Plastic and Reconstructive Surgery. 7(1). 54–60. 48 indexed citations
19.
Borodic, Gary E., et al.. (1990). Botulinum a toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spread. Head & Neck. 12(5). 392–399. 136 indexed citations
20.
Borodic, Gary E. & David J. Cozzolino. (1989). Blepharospasm and Its Treatment, with Emphasis on the Use of Botulinum Toxin. Plastic & Reconstructive Surgery. 83(3). 546–554. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Lozza Breakdown of academic impact, for papers by Andrew Blitzer Breakdown of academic impact, for papers by Yeşim Parman Breakdown of academic impact, for papers by Namita Goyal Breakdown of academic impact, for papers by Maik Ellies Breakdown of academic impact, for papers by Elizabeth A. Sekul Breakdown of academic impact, for papers by P. van Doorn Breakdown of academic impact, for papers by Daniel P. Stein Breakdown of academic impact, for papers by Ruple S. Laughlin Breakdown of academic impact, for papers by Eduardo Fernández
Rankless by CCL
2026